Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID)

Immunology

Volumn 95, Issue 1, 1998, Pages 47-55

  D'Orazio, T J ^a   Niederkorn, J Y ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; COCULTURE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; HUMORAL IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE;

ANIMALS; ANTERIOR CHAMBER; ANTIGEN PRESENTATION; B-LYMPHOCYTES; EYE DISEASES; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; SPLEEN; T-LYMPHOCYTES;

EID: 0031661152     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00581.x     Document Type: Article

References (44)

1. NIEDERKORN J.Y. (1990) Immune privilege and immune regulation in the eye. Adv Immunol 48, 191.
2. MEDAWAR P. (1948) Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29, 58.
3. STREILEIN J.W. (1993) Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 5, 428.
4. GRIFFITH T.S., BRUNNER T., FLETCHER S.M., GREEN D. R. & FERGUSON T.A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege [sec comments]. Science 270, 1189.
5. STREILEIN J.W. & NIEDERKORN J.Y. (1981) Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 153, 1058.
6. STREILEIN J.W. (1995) Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye 9, 236.
7. NIEDERKORN J.Y. & STREILEIN J.W. (1982) Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors docs not require splenic metastases. J Immunol 128, 2470.
8. WILBANKS G.A. & STREILEIN J.W. (1989) The differing patterns of antigen release and local retention following anterior chamber and intravenous inoculation of soluble antigen. Evidence that the eye acts as an antigen depot. Reg Immunol 2, 390.
9. YAO Y.-F., INOUE Y., MIYAZAKI D. et al. (1997) The antigen-bearing eye and the spleen are indispensable in maintaining anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 38, 534.
10. FERGUSON T.A. & HERNDON J.M. (1994) The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen. Invest Ophthalmol Vis Sci 35, 3085.
11. STREILEIN J.W., OKAMOTO S., HARA Y., KOSIEWICZ, M. & KSANDER B. (1997) Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen. Invest Ophthalmol Vis Sci 38, 2245.
12. WILBANKS G.A. & STREILEIN J.W. (1991) Studies on the induction of anterior chamber-associated immune deviation (ACAID). I. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 146, 2610.
13. WILBANKS G.A. & STREILEIN J.W. (1992) Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg Immunol 4, 130.
14. WILBANKS G.A., MAMMOLENTI M. & STREILEIN J.W. (1992) Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol 22, 165.
15. WILBANKS G.A., MAMMOLENTI M. & STREILEIN J.W. (1991) Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol 146, 3018.
16. HARA Y., CASPI R.R., WIGGERT B., DORF M. & STREILEIN J.W. (1992) Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye [published erratum appears in J Immunol 1992 Dec 15;149(12):4116]. J Immunol 149, 1531.
17. HARA Y., OKAMOTO S., ROUSE B. & STREILEIN J.W. (1993) Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. J Immunol 151, 5162.
18. NIEDERKORN J.Y. & MAYHEW E. (1995) Role of splenic B cells in the immune privilege of the anterior chamber of the eye. Eur J Immunol 25, 2783.
19. GRIFFITH T.S., YU X., HERNDON J.M., GREEN D.R. & FERGUSON T.A. (1996) CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5, 7.
20. LI X.Y., D'ORAZIO T.J. & NIEDERKORN J.Y. (1996) Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 89, 34.
21. TAKEUCHI M., KOSIEWICZ M.M., ALARD P. & STREILEIN J.W. (1997) On the mechanisms by which transforming growth factor-beta-2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol 27, 1648.
22. GAJEWSKI T.F., PINNAS M., WONG T. & FITCH F.W. (1991) Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol 146, 1750.
23. MACAULAY A.E., DEKRUYFF R.H., GOODNOW C.C. & UMETSU D.T. (1997) Antigen-specific B cells preferentially induce CD4 + T cells to produce IL-4. J Immunol 158, 4171.
24. WILBANKS G.A. & STREILEIN J.W. (1990) Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71, 383.
25. WILBANKS G.A. & STREILEIN J.W. (1992) Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol 22, 1031.
26. KITAMURA D., ROES J., KUHN R. & RAJEWSKY K. (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423.
27. STREILEIN J.W., KSANDER B.R. & TAYLOR A.W. (1997) Immune deviation in relation to ocular immune privilege. J Immunol 158, 3557.
28. SMITH R.E., JENSEN A.D. & SILVERSTEIN A.M. (1969) Antibody formation by single cells during experimental immunogenic uveitis. Invest Ophthalmol 8, 373.
29. KAPLAN H.J., STREILEIN J.W. & STEVENS T.R. (1975) Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells. J Immunol 115, 805.
30. KAPLAN H.J. & STREILEIN J.W. (1974) Do immunologically privileged sites require a functioning spleen? Nature 251, 553.
31. STREILEIN J.W. & STREILEIN J.S. (1973) Immunologic reactivity to weak transplantation antigens: factors which favor sensitization rather than tolerance. J Natl Cancer Inst 51, 1589.
32. LAGRANGE P.H., MACKANESS G.B. & MILLER T.E. (1974) Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med 139, 528.
33. MACKANESS G.B., LAGRANGE P.H., MILLER T.E. & ISHIBASHI T. (1974) Feedback inhibition of specifically sensitized lymphocytes, J Exp Med 139, 543.
34. LAGRANGE P.H., MACKANESS G.B. & MILLER T.E. (1974) Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med 139, 1529.
35. BENACERRAF B. & GERMAIN R.N. (1981) A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression. Scand J Immunol 13, 1.
36. KOSIEWICZ M.M., OKAMOTO S., MIKI S., KSANDER B.R., SHIMIZU T. & STREILEIN J.W. (1994) Imposing deviant immunity on the presensitized state. J Immunol 153, 2962.
37. MAN-SUN S., MILLER S.D., KOWACH H.B. & CLAMAN H.N. (1977) A splenic requirement for the generation of suppressor T cells. J Immunol 119, 2095.
38. KEHRL J.H., ROBERTS A.B., WAKEFIELD L.M., JAKOWLEW S., SPORN M.B. & FAUCI A.S. (1986) Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol 137, 3855.
39. O'GARRA A. & HOWARD M. (1992) IL-10 production by CD5 B cells. Ann N Y Acad Sci 651, 182.
40. GIENI R.S., UMETSU D.T. & DEKRUYFF R.H. (1997) Lyl- (CD5-) B cells produce interleukin (IL)-10. Cell Immunol 175, 164.
41. EYNON E.E. & PARKER D.C. (1991) Do small B cells induce tolerance? Transplant Proc 23, 729.
42. EYNON E.E. & PARKER D.C. (1992) Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 175, 131.
43. PARKER D.C. & EYNON E.E. (1991) Antigen presentation in acquired immunological tolerance. Faseb J 5, 2777.
44. NOBLE A., ZHAO Z.S. & CANTOR H. (1998) Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 suppression of T helper 2 responses. J Immunol 160, 566.